Loading…
Underlying
Underlying Price
$8.48
Type
Call
Strike
19.5
Expiration
Oct 23, 2026
DTE
3d
Moneyness
OTM
Intrinsic
$0.00
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.